{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:25:33Z","timestamp":1769106333877,"version":"3.49.0"},"reference-count":31,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1939,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1540-8159.2010.02789.x","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T15:27:52Z","timestamp":1273591672000},"page":"1203-1209","source":"Crossref","is-referenced-by-count":7,"title":["Exercise-Induced Natriuretic Peptide Secretion Predicts Cardioversion Outcome in Patients with Persistent Atrial Fibrillation: Discordant ANP and B-Type Natriuretic Peptide Response to Exercise Testing"],"prefix":"10.1111","volume":"33","author":[{"given":"BEATA","family":"WOZAKOWSKA-KAPLON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GRZEGORZ","family":"OPOLSKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,11]]},"reference":[{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate versus rhythm control in patients with atrial fibrillation. A meta-analysis","volume":"165","author":"De Denus","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.ehj.2004.06.020","article-title":"RACE study group. Rate control is more costeffective than rhythm control for patients with persistent atrial fibrillation - results from the Rate Control versus Electrical Cardioversion (RACE) study","volume":"25","author":"Hagens","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB5|cit5","first-page":"254","article-title":"Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation","volume":"67","author":"Wo\u017cakowska-Kap\u0142on","year":"2009","journal-title":"Kardiol Pol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB6|cit6","first-page":"260","article-title":"ACC\/AHA guidelines for exercise testing: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing)","volume":"30","author":"Gibbons","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB7|cit7","first-page":"219","volume-title":"Atrial Fibrillation. Mechanisms and Management","author":"Atwood","year":"1997"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB8|cit8","first-page":"1979","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)","volume":"27","author":"Fuster","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijcard.2004.08.062","article-title":"The dubious value of echocardiographic and plasma ANP measurements in predicting outcome of cardioversion in patients with persistent atrial fibrillation","volume":"193","author":"Wozakowska-Kaplon","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1540-8159.2000.tb07042.x","article-title":"An increase in plasma atrial natriuretic peptide concentration during exercise predicts a successful cardioversion and maintenance of sinus rhythm in patients with chronic atrial fibrillation","volume":"23","author":"Wozakowska-Kaplon","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1388-9842(01)00232-X","article-title":"Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure","volume":"4","author":"Van Den Berg","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB12|cit12","first-page":"513","article-title":"Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure","volume":"61","author":"Wozakowska-Kaplon","year":"2004","journal-title":"Kardiol Pol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1054-8807(99)00038-1","article-title":"Structural changes of atrial myocardium during chronic atrial fibrillation","volume":"9","author":"Thijssen","year":"2000","journal-title":"Cardiovasc Pathol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/01.CIR.0000034511.06350.DF","article-title":"Atrial amyloidosis: An arrhythmogenic substrate for persistent atrial fibrillation","volume":"106","author":"R\u00f6cken","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0735-1097(01)01719-3","article-title":"Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation. Plasma ANP as a possible biochemical marker to predict the outcome of the Maze procedure","volume":"39","author":"Yoshihara","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0735-1097(99)00563-X","article-title":"Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: A prospective study","volume":"35","author":"Yamada","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9149(03)00478-8","article-title":"Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure","volume":"92","author":"Larsen","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2004.10.046","article-title":"Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation","volume":"105","author":"Engelmann","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0167-5273(02)00065-7","article-title":"Atrial natriuretic peptide in atrial fibrillation: A protective but time-limited system","volume":"83","author":"Van Den Berg","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1253\/circj.72.921","article-title":"NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation","volume":"72","author":"M\u00f6llmann","year":"2008","journal-title":"Circ J"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB21|cit21","first-page":"1245","article-title":"Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm","volume":"20","author":"Beck-da-Silva","year":"2004","journal-title":"Can J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1540-8159.2008.01121.x","article-title":"Sinus rhythm restoration after atrial fibrillation: The clinical value of N-terminal pro-BNP measurements","volume":"31","author":"Danicek","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB23|cit23","article-title":"ANP and B-type peptide: Twins or kins? Different predictive value in atrial fibrillation","author":"Wozakowska-Kap\u0142on","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.CIR.0000134481.24511.BC","article-title":"Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery","volume":"110","author":"Wazni","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.amjcard.2004.03.013","article-title":"Effects of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation","volume":"93","author":"Wozakowska-Kaplon","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/eurheartj\/ehm577","article-title":"Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions","volume":"29","author":"Sacher","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1253\/jcj.64.765","article-title":"Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with congestive heart failure","volume":"64","author":"Mabuchi","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1253\/jcj.64.965","article-title":"Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome","volume":"64","author":"Horie","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels at risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.CIR.87.2.464","article-title":"Different secretion patterns of atrial and brain natriuretic peptide in patients with congestive heart failure","volume":"87","author":"Yoshimura","year":"1993","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8159.2010.02789.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2004.09.045","article-title":"Discordant atrial natriuretic peptide and brain natriuretic levels in lone atrial fibrillation","volume":"45","author":"Ellinor","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2010.02789.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1540-8159.2010.02789.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:14:26Z","timestamp":1625548466000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2010.02789.x"}},"subtitle":["NATRIURETIC PEPTIDES IN ATRIAL FIBRILLATION"],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":31,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2010.02789.x","relation":{},"ISSN":["0147-8389"],"issn-type":[{"value":"0147-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}